Chapter 31: Diuretics, Kidney Diseases

Written By: Razaullah Khattak (DPT Medical Professional)

Student Source Reference: Guyton and Hall Textbook of Medical Physiology

Chapter: 31

To read more check out Chapter 13:

https://mednotesbyrazaullah.blogspot.com/2026/08/chapter-13-cardiac-arrhythmias-and.html

Diuretics and Their 
Mechanisms of 
Action 

Diuretics are pharmacological agents that enhance the rate of urine volume output primarily by inhibiting the tubular reabsorption of sodium and chloride. By retaining sodium within the renal tubules, diuretics create an osmotic gradient that decreases water reabsorption, leading to increased urinary excretion of water and various electrolytes. Clinically, these agents serve as a primary therapeutic intervention to reduce expanded extracellular fluid volume in disorders such as hypertension and edematous states.

Initial diuretic administration can dramatically elevate urine output, compensatory mechanisms including arterial pressure reductions, decreased glomerular filtration rate, and activation of the renin-angiotensin system eventually restore fluid balance at lower extracellular fluid volumes. Diuretics are categorized based on their specific tubular sites of action and distinct transport mechanisms along the nephron.

General Principles of Diuretic Action

• Diuretics increase urine volume output rate.
• Most diuretics increase solute excretion rates.
• Sodium and chloride excretion increases significantly.
• Reduced sodium reabsorption drives osmotic diuresis.
• Water output increases secondary to sodium loss.
• Diuretics raise excretion of potassium and calcium.
• Main clinical use is reducing fluid volume.
• Used frequently to treat clinical edema states.
• Used extensively to treat systemic hypertension.
• Decreased fluid volume activates renal compensatory mechanisms.
• Compensatory responses reduce initial high urine output.
• Angiotensin II formation increases during fluid loss.
• Arterial pressure drops during chronic diuretic therapy.
• Fluid intake equals output in steady state.

Osmotic Diuretics Mechanism

• Osmotic diuretics increase tubular fluid solute concentration.
• Non-reabsorbed substances raise tubular osmotic pressure.
• High tubular osmotic pressure inhibits water reabsorption.
• Urea acts as an osmotic diuretic agent.
• Mannitol is a non-reabsorbed osmotic diuretic.
• Sucrose raises osmotic pressure in tubular fluid.
• High blood glucose causes osmotic diuresis.
• Diabetes mellitus exceeds glucose transport maximum capacity.
• Unreabsorbed glucose remains inside renal tubular lumen.
• Unreabsorbed tubular glucose prevents normal water reabsorption.
• Osmotic diuresis causes severe urinary fluid loss.
• High urine output activates central thirst mechanisms.

Loop Diuretics Mechanism

• Furosemide acts on thick ascending loop.
• Ethacrynic acid blocks loop transport mechanisms.
• Bumetanide inhibits thick ascending limb transport.
• Loop diuretics block 1-Na+-2Cl--1K+ co-transporter protein.
• Co-transporter block occurs at luminal membrane.
• Solute delivery to distal nephron increases.
• Increased distal solutes act as osmotic agents.
• Countercurrent multiplier system is disrupted significantly.
• Renal medullary interstitial fluid osmolarity decreases.
• Urinary concentrating ability becomes severely impaired.
• Urinary diluting ability becomes severely impaired.
• Descending loop water reabsorption decreases markedly.
• Up to 30 percent filtrate is excreted.
• Urine output increases up to 25-fold.

Thiazide Diuretics Mechanism

• Chlorothiazide acts on early distal tubule.
• Thiazides block luminal sodium-chloride co-transporter protein.
• Early distal tubule reabsorption is inhibited.
• Up to 10 percent filtrate is excreted.
• Thiazides cause moderate salt and water loss.

Carbonic Anhydrase Inhibitors Mechanism

• Acetazolamide inhibits carbonic anhydrase enzyme activity.
• Primary action site is proximal tubular epithelium.
• Intercalated cells also contain carbonic anhydrase.
• Sodium-hydrogen counter-transport depends on carbonic anhydrase.
• Decreased bicarbonate reabsorption reduces sodium reabsorption.
• Unreabsorbed bicarbonate acts as osmotic diuretic agent.
• Excessive bicarbonate loss causes metabolic acidosis.

Aldosterone Antagonists Mechanism

• Spironolactone competes with mineralocorticoid receptor binding.
• Eplerenone blocks cortical collecting tubule receptors.
• Aldosterone receptor blockade reduces sodium reabsorption.
• Aldosterone blockade decreases tubular potassium secretion.
• Unreabsorbed sodium acts as osmotic diuretic.
• Potassium excretion decreases, causing potassium sparing.
• Extracellular fluid potassium concentration may rise.

Sodium Channel Blockers Mechanism

• Amiloride blocks luminal membrane sodium channels.
• Triamterene inhibits entry through luminal channels.
• Channel blockage decreases basolateral Na+-K+ ATPase.
• Reduced ATPase activity impairs potassium entry.
• Potassium secretion into tubular fluid decreases.
• Sodium channel blockers spare potassium excretion.

Kidney Diseases

• Kidney diseases cause severe global disability.
• Chronic kidney disease affects millions of adults.
• Diseases divide into acute and chronic failure.
• Acute failure involves abrupt loss of function.
• Acute renal failure may allow complete recovery.
• Chronic failure involves progressive nephron loss.
• Kidney diseases affect vasculature, glomeruli, and tubules.

Prerenal Acute Renal Failure

• Prerenal failure stems from diminished renal flow.
• Kidneys receive 20 to 25 percent output.
• High flow provides plasma for filtration.
• Decreased blood flow lowers overall GFR.
• Oliguria means diminished daily urine output.
• Anuria means total cessation of urine.
• Heart failure reduces renal perfusion pressure.
• Severe hemorrhage causes volume depletion failure.
• Shock causes peripheral vasodilation and hypotension.
• Renal ischemia below 25 percent causes hypoxia.
• Reduced GFR lowers tubular oxygen demand.
• Persistent ischemia leads to intrarenal damage.

Intrarenal Acute Renal Failure

• Intrarenal failure originates within renal tissue.
• Injury targets glomerular capillaries or vessels.
• Damage affects tubular epithelium or interstitium.
• Glomerulonephritis follows streptococcal immune reaction.
• Immune complexes deposit in glomerular membranes.
• Mesangial cells proliferate during immune reaction.
• Entrapped leukocytes block glomerular capillary lumens.
• Inflamed glomeruli leak protein and red cells.
• Acute tubular necrosis damages tubular epithelium.
• Severe ischemia causes tubular epithelial sloughing.
• Sloughed tubular cells plug nephron lumens.
• Toxins destroy tubular epithelial cell lining.
• Carbon tetrachloride causes severe tubular necrosis.
• Heavy metals cause toxic tubular damage.
• Ethylene glycol damages tubular epithelial cells.
• Insecticides cause direct toxic epithelial necrosis.
• Intact basement membrane allows tubular cell regeneration.
• Epithelial repair requires 10 to 20 days.

Postrenal Acute Renal Failure

• Postrenal failure stems from urinary obstruction.
• Unilateral obstruction allows contralateral kidney compensation.
• Bilateral ureteral obstruction causes acute failure.
• Kidney stones cause urinary tract obstruction.
• Bladder obstruction causes urine outflow failure.
• Urethral obstruction leads to postrenal damage.
• Chronic obstruction causes irreversible tissue damage.

Physiologic Effects of Acute Failure

• Water and electrolyte retention occurs rapidly.
• Waste products accumulate in extracellular fluid.
• Fluid overload causes edema and hypertension.
• Hyperkalemia above 8 mEq/L becomes fatal.
• Inability to excrete hydrogen causes acidosis.
• Complete anuria causes death within days.

Chronic Renal Failure

• Chronic failure is irreversible nephron loss.
• Clinical symptoms appear after 70 percent loss.
• Electrolyte balance persists until 80 percent loss.

Disclaimer: This content is for educational purposes only and not a substitute for professional medical advice.